Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
19,25 EUR | +0,44% |
|
+3,52% | +15,66% |
14/02 | West Pharmaceutical Services-aandeel bereikt 'aantrekkelijk instappunt' volgens Deutsche Bank | MT |
14/02 | Informatica laat meer vragen dan antwoorden achter na Q4, zegt Deutsche Bank | MT |
Toevoegen aan een lijst 0 geselecteerde | Dividendrendement (Y) | Dividendrendement (Y+1) | P/E-ratio (Y) | Koers-boekwaarde (Y) | EV/omzet (Y) | Beurskap. / EBITDA (Y) | Beurskap. / EBIT (Y) | Kapi.($) | |
---|---|---|---|---|---|---|---|---|---|
3,53% | 5,16% | 12.54x | 0.58x | 0.7x | - | 3.02x | 39,31 mld. | ||
1,74% | 1,91% | 14.82x | 2.36x | - | - | - | 774 mld. | ||
2,14% | 2,3% | 14.74x | 1.32x | - | - | - | 357 mld. | ||
5,76% | 5,82% | 5.38x | 0.51x | - | - | - | 323 mld. | ||
1,89% | 2,12% | 15.05x | 1.6x | - | - | - | 263 mld. | ||
6,49% | 6,58% | 4.68x | 0.48x | - | - | - | 216 mld. | ||
6,16% | 6,22% | 5.27x | 0.48x | - | - | - | 203 mld. | ||
7,91% | 6,02% | 8.76x | 1.14x | - | - | - | 193 mld. | ||
2,92% | 2,99% | 26.95x | 3.63x | - | - | - | 176 mld. | ||
3,56% | 3,8% | 13.7x | 1.89x | - | - | - | 168 mld. | ||
1,2% | 1,34% | 19.29x | 2.63x | - | - | - | 150 mld. | ||
3,1% | 3,46% | 12.38x | 1.11x | - | - | - | 148 mld. | ||
4,73% | 4,85% | 7.32x | 1.04x | - | - | - | 146 mld. | ||
4,95% | 5,21% | 12.45x | 1.3x | - | - | - | 105 mld. | ||
3,16% | 3,52% | 11.95x | 0.98x | - | - | - | 96,89 mld. | ||
5,13% | 6,67% | 11.3x | 1.94x | - | - | - | 95,09 mld. | ||
3,43% | 3,7% | 7.58x | 0.9x | - | - | - | 91,91 mld. | ||
6,83% | 7,19% | 7.3x | 0.7x | - | - | - | 83 mld. | ||
7,64% | 8,42% | 9.11x | 1.32x | - | - | - | 82,14 mld. | ||
4,18% | 4,23% | 18.02x | 1.99x | - | - | - | 79,85 mld. | ||
Gemiddelde | percentage-no-prefix | percentage-no-prefix | 11,93x | 1,40x | 0,70x | - | 3,02x | 189,52 mld. | |
Gewogen gemiddelde per kap. | percentage-no-prefix | percentage-no-prefix | 12,28x | 1,54x | 0,70x | - | 3,02x |
- Beurs
- Aandelen
- Koers DBK
- Sector Deutsche Bank AG
- Sectorale dividenden